ASH on XNYS, Wholesale Trade, Ashland Inc., job postings
Measures activity, not value. Not investment advice.
Free cash flow of $297M far exceeds $4M profit as shares rose 50% in a year.
GoodInstitutional holders rose to 374 from 350, up 6.9%
Written by AI from the data on this page, 22 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 30 Sep 2026
Ashland Inc. is a specialty materials company serving markets including pharmaceuticals, personal care, food and beverages, coatings, construction, energy, and electronics. It operates through four segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. Life Sciences contributes the highest revenue, offering functional additives for pharmaceutical and nutrition applications. Personal Care provides ingredients for skin, hair, oral care, and household products, while Specialty Additives supplies performance-enhancing additives for coatings and. Intermediates produce BDO and related derivatives used in polymers, electronics, agriculture, and pharmaceutical applications. The company generates sales across North America, Europe, Asia Pacific, Latin America, and regions.
expected around 1 Feb 2027 (an estimate: a year ago it reported on 2 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $498.0M, net loss $16.0M.
31 Dec 2021RevenueNet incomeNet losstallest bar $786.0M30 Sep 2026
See the numbers
Quarter to
Revenue
Net income
30 Sep 2026
$498.0M
-$16.0M
30 Jun 2026
$497.0M
$16.0M
31 Mar 2026
$482.0M
$16.0M
31 Dec 2025
$386.0M
-$12.0M
30 Sep 2025
$477.0M
$32.0M
30 Jun 2025
$463.0M
-$742.0M
31 Mar 2025
$479.0M
$31.0M
31 Dec 2024
$405.0M
-$165.0M
30 Sep 2024
$522.0M
$16.0M
30 Jun 2024
$544.0M
$6.0M
31 Mar 2024
$575.0M
$120.0M
31 Dec 2023
$473.0M
$26.0M
30 Sep 2023
$517.0M
-$4.0M
30 Jun 2023
$546.0M
$50.0M
31 Mar 2023
$603.0M
$91.0M
31 Dec 2022
$525.0M
$40.0M
30 Sep 2022
–
$57.0M
30 Jun 2022
$644.0M
$36.0M
31 Mar 2022
$604.0M
$786.0M
31 Dec 2021
$512.0M
$48.0M
Fundamentals, 12 months to 30 Sep 2026
Measure
Latest
Year before
Peer median
RevenueiSales over the last 12 months reported.
$1.9B
$1.8B
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
+2.1%
+6.7%
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
$4.0M
-$845.0M
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
$0.09
-$18.23
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
32.3%
30.1%
20.9%
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
5.6%
-42.5%
3.0%
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
0.2%
-46.3%
1.3%
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
0.2%
7.9%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
$297.0M
$36.0M
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$480.0M
$215.0M
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
$1.4B
$1.4B
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
$891.0M
$1.2B
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
0.74
0.59
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
$40.32
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
830
18.8
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
1.8
0.64
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
2.3
0.77
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
1.8
1.9
Dividend yieldiDividends per share declared in the latest fiscal year divided by the share price.
2.3%
1.4%
Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Peers nearest by market cap, its own industry first
Insider Buy/Sell iShares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.
–
No data for this company
Institutional holders iThe number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.
+6.9%
374 13F filers vs 350
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
over 100%
51.1M shares held by 13F filers (30 Sep 2026) of 45.8M outstanding (31 Oct 2026); above 100%: the share count is probably stale
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
11%
5.1M shares sold short (30 Oct 2026) of 45.8M outstanding (31 Oct 2026)
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
12.1
5.1M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
+0.1%
5.1M shares sold short in the report before, 5.1M on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
55%
55% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 66%
Open jobs iJob postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.
–
We do not track this company's careers site yet.
Open jobs change iHow the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.
–
We do not track this company's careers site yet.
Employees iTotal staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.
–
No headcount in its annual reports in our data.
Visa hiring (foreign workers) iApplications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.
–
No data for this company
Revenue growth iSales in the latest reported quarter compared with the same quarter a year earlier.
+4.4%
$498.0M vs $477.0M (quarter ended 30 Sep 2026)
Capital spending iMoney spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.
+8.8%
$37.0M vs $34.0M (quarter ended 30 Sep 2026)
Federal contracts iMoney the US government committed to the company in contracts and grants over the last 12 months.
–
No data for this company
Lobbying iWhat the company reported spending on federal lobbying over the last four quarters.
–
No data for this company
Layoff notices iWorkers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).
–
No data for this company
News (7d) iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
32
32 articles in the last 7 days; its usual week has 3 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
11×
32 articles in the last 7 days; its usual week has 3.
Price $72.40 on 20 Nov 2026, +50% over 12 months (12-month range $48.18 to $77.70)
Sharp change
8-K and other filings
WARN layoff notice
Insider net buying (open market). Insiders bought a net $0 in the last 12 months (the 12 months before: $2.2M).H-1B/E-3 applications certified. H-1B/E-3 applications certified: 0 published in the last 12 months, -100% on the 12 months before.Revenue per quarter. Revenue $498.0M in the latest quarter, +4.4% on a year earlier.Capital spending per quarter. Capital spending $37.0M in the latest quarter, +8.8% on a year earlier.Institutional holders (13F filers). 374 13F filers reported holding it in the latest 13F quarter, +12% on a year earlier.Workers in WARN layoff notices. Workers in WARN layoff notices: 0 published in the last 12 months, -100% on the 12 months before.
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: federal obligations, lobbying spend.
Quarter ended 31 Dec 2021: $512.0M, -7.2% on a year earlier; public on 4 Feb 2022
Quarter ended 31 Mar 2022: $604.0M, +1.0% on a year earlier; public on 29 Apr 2022
Quarter ended 30 Jun 2022: $644.0M, +1.1% on a year earlier; public on 29 Jul 2022
Quarter ended 31 Dec 2022: $525.0M, +2.5% on a year earlier; public on 2 Feb 2023
Quarter ended 31 Mar 2023: $603.0M, -0.2% on a year earlier; public on 4 May 2023
Quarter ended 30 Jun 2023: $546.0M, -15% on a year earlier; public on 28 Jul 2023
Quarter ended 30 Sep 2023: $517.0M; public on 18 Nov 2023
Quarter ended 31 Dec 2023: $473.0M, -9.9% on a year earlier; public on 1 Feb 2024
Quarter ended 31 Mar 2024: $575.0M, -4.6% on a year earlier; public on 2 May 2024
Quarter ended 30 Jun 2024: $544.0M, -0.4% on a year earlier; public on 8 Aug 2024
Quarter ended 30 Sep 2024: $522.0M, +1.0% on a year earlier; public on 19 Nov 2024
Quarter ended 31 Dec 2024: $405.0M, -14% on a year earlier; public on 30 Jan 2025
Quarter ended 31 Mar 2025: $479.0M, -17% on a year earlier; public on 2 May 2025
Quarter ended 30 Jun 2025: $463.0M, -15% on a year earlier; public on 31 Jul 2025
Quarter ended 30 Sep 2025: $477.0M, -8.6% on a year earlier; public on 21 Nov 2025
Quarter ended 31 Dec 2025: $386.0M, -4.7% on a year earlier; public on 4 Feb 2026
Quarter ended 31 Mar 2026: $482.0M, +0.6% on a year earlier; public on 30 Apr 2026
Quarter ended 30 Jun 2026: $497.0M, +7.3% on a year earlier; public on 30 Jul 2026
Quarter ended 30 Sep 2026: $498.0M, +4.4% on a year earlier; public on 21 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $15.0M, -50% on a year earlier; public on 4 Feb 2022
Quarter ended 31 Dec 2022: $23.0M, +53% on a year earlier; public on 2 Feb 2023
Quarter ended 31 Mar 2023: $35.0M; public on 4 May 2023
Quarter ended 30 Jun 2023: $43.0M; public on 28 Jul 2023
Quarter ended 30 Sep 2023: $69.0M; public on 18 Nov 2023
Quarter ended 31 Dec 2023: $36.0M, +57% on a year earlier; public on 1 Feb 2024
Quarter ended 31 Mar 2024: $34.0M, -2.9% on a year earlier; public on 2 May 2024
Quarter ended 30 Jun 2024: $29.0M, -33% on a year earlier; public on 8 Aug 2024
Quarter ended 30 Sep 2024: $38.0M, -45% on a year earlier; public on 19 Nov 2024
Quarter ended 31 Dec 2024: $23.0M, -36% on a year earlier; public on 30 Jan 2025
Quarter ended 31 Mar 2025: $21.0M, -38% on a year earlier; public on 2 May 2025
Quarter ended 30 Jun 2025: $20.0M, -31% on a year earlier; public on 31 Jul 2025
Quarter ended 30 Sep 2025: $34.0M, -11% on a year earlier; public on 21 Nov 2025
Quarter ended 31 Dec 2025: $14.0M, -39% on a year earlier; public on 4 Feb 2026
Quarter ended 31 Mar 2026: $17.0M, -19% on a year earlier; public on 30 Apr 2026
Quarter ended 30 Jun 2026: $20.0M, 0% on a year earlier; public on 30 Jul 2026
Quarter ended 30 Sep 2026: $37.0M, +8.8% on a year earlier; public on 21 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 294; public on 14 Feb 2022
31 Mar 2022 report: 296; public on 16 May 2022
30 Jun 2022 report: 318; public on 15 Aug 2022
30 Sep 2022 report: 303; public on 14 Nov 2022
31 Dec 2022 report: 331; public on 14 Feb 2023
31 Mar 2023 report: 332; public on 15 May 2023
30 Jun 2023 report: 305; public on 14 Aug 2023
30 Sep 2023 report: 303; public on 14 Nov 2023
31 Dec 2023 report: 316; public on 14 Feb 2024
31 Mar 2024 report: 351; public on 15 May 2024
30 Jun 2024 report: 359; public on 14 Aug 2024
30 Sep 2024 report: 351; public on 14 Nov 2024
31 Dec 2024 report: 351; public on 14 Feb 2025
31 Mar 2025 report: 355; public on 15 May 2025
30 Jun 2025 report: 333; public on 14 Aug 2025
30 Sep 2025 report: 335; public on 14 Nov 2025
31 Dec 2025 report: 313; public on 17 Feb 2026
31 Mar 2026 report: 334; public on 15 May 2026
30 Jun 2026 report: 350; public on 14 Aug 2026
30 Sep 2026 report: 374; public on 16 Nov 2026
Workers in WARN layoff notices
Month from 1 Feb 2023: 10 published
Month from 1 Aug 2025: 55 published
What is unusual now
Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market buying (USD, Form 4) at $2.2M (3 Feb 2025), higher than 95% of its own history.
Reported lobbying spend: $20K in Q2 2021, $20K in Q1 2021. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.
Reauthorization of Federal Transportation Programs (Safe, Accountable, Flexible, Efficient Transportation Equity Act: A Legacy for Users, P.L. 109-59 ); composite bridge construction authorization; composite pier construction.; Magnuson-Moss Warranty Act investigation request for the Federal Trade Commission into exclusion of automobile warranty coverage.; Investment tax credit sought for re-refiners of used motor oil.; Classification of Styrene by Department of Health and Human Services. National Academy of Sciences funding for study of styrene.Transportation, Consumer safety, Taxation, Health issues
had 5.5M shares sold short in the 15 Apr 2026 report, 4.1× the same report last year.
Same report last year: 1.3M; its normal report is 1.8M.
See the evidence
This period
5.5M (the 15 Apr 2026 report)
Normal report (median of 24 earlier)
1.8M
Typical spread (median absolute deviation)
474K
How far from its usual level
+5.2
Same report last year
1.3M
History used
3,029 days
the 15 Apr 2026 report24 earlier reportsnormal: 1.8M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 4.9M shares sold short in the 31 Mar 2026 report, 4.2× the same report last year.
Same report last year: 1.2M; its normal report is 1.6M.
See the evidence
This period
4.9M (the 31 Mar 2026 report)
Normal report (median of 24 earlier)
1.6M
Typical spread (median absolute deviation)
340K
How far from its usual level
+6.5
Same report last year
1.2M
History used
3,014 days
the 31 Mar 2026 report24 earlier reportsnormal: 1.6M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 5.0M shares sold short in the 13 Mar 2026 report, 3.3× the same report last year.
Same report last year: 1.5M; its normal report is 1.6M.
See the evidence
This period
5.0M (the 13 Mar 2026 report)
Normal report (median of 24 earlier)
1.6M
Typical spread (median absolute deviation)
257K
How far from its usual level
+8.9
Same report last year
1.5M
History used
2,996 days
the 13 Mar 2026 report24 earlier reportsnormal: 1.6M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 5.0M shares sold short in the 27 Feb 2026 report, 3.0× the same report last year.
Same report last year: 1.7M; its normal report is 1.6M.
See the evidence
This period
5.0M (the 27 Feb 2026 report)
Normal report (median of 24 earlier)
1.6M
Typical spread (median absolute deviation)
235K
How far from its usual level
+9.8
Same report last year
1.7M
History used
2,982 days
the 27 Feb 2026 report24 earlier reportsnormal: 1.6M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 4.2M shares sold short in the 13 Feb 2026 report, 2.9× the same report last year.
Same report last year: 1.4M; its normal report is 1.6M.
See the evidence
This period
4.2M (the 13 Feb 2026 report)
Normal report (median of 24 earlier)
1.6M
Typical spread (median absolute deviation)
196K
How far from its usual level
+9.0
Same report last year
1.4M
History used
2,968 days
the 13 Feb 2026 report24 earlier reportsnormal: 1.6M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 3.9M shares sold short in the 30 Jan 2026 report, 2.5× the same report last year.
Same report last year: 1.6M; its normal report is 1.6M.
See the evidence
This period
3.9M (the 30 Jan 2026 report)
Normal report (median of 24 earlier)
1.6M
Typical spread (median absolute deviation)
154K
How far from its usual level
+10.1
Same report last year
1.6M
History used
2,954 days
the 30 Jan 2026 report24 earlier reportsnormal: 1.6M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 3.8M shares sold short in the 15 Jan 2026 report, 2.8× the same report last year.
Same report last year: 1.4M; its normal report is 1.6M.
See the evidence
This period
3.8M (the 15 Jan 2026 report)
Normal report (median of 24 earlier)
1.6M
Typical spread (median absolute deviation)
138K
How far from its usual level
+11.0
Same report last year
1.4M
History used
2,939 days
the 15 Jan 2026 report24 earlier reportsnormal: 1.6M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 4.1M shares sold short in the 31 Dec 2025 report, 3.4× the same report last year.
Same report last year: 1.2M; its normal report is 1.5M.
See the evidence
This period
4.1M (the 31 Dec 2025 report)
Normal report (median of 24 earlier)
1.5M
Typical spread (median absolute deviation)
119K
How far from its usual level
+14.7
Same report last year
1.2M
History used
2,924 days
the 31 Dec 2025 report24 earlier reportsnormal: 1.5M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 3.8M shares sold short in the 15 Dec 2025 report, 3.5× the same report last year.
Same report last year: 1.1M; its normal report is 1.5M.
See the evidence
This period
3.8M (the 15 Dec 2025 report)
Normal report (median of 24 earlier)
1.5M
Typical spread (median absolute deviation)
131K
How far from its usual level
+11.8
Same report last year
1.1M
History used
2,908 days
the 15 Dec 2025 report24 earlier reportsnormal: 1.5M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 4.4M shares sold short in the 28 Nov 2025 report, 4.1× the same report last year.
Same report last year: 1.1M; its normal report is 1.5M.
See the evidence
This period
4.4M (the 28 Nov 2025 report)
Normal report (median of 24 earlier)
1.5M
Typical spread (median absolute deviation)
126K
How far from its usual level
+15.4
Same report last year
1.1M
History used
2,891 days
the 28 Nov 2025 report24 earlier reportsnormal: 1.5M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 3.4M shares sold short in the 14 Nov 2025 report, 3.4× the same report last year.
Same report last year: 1.0M; its normal report is 1.5M.
See the evidence
This period
3.4M (the 14 Nov 2025 report)
Normal report (median of 24 earlier)
1.5M
Typical spread (median absolute deviation)
121K
How far from its usual level
+11.0
Same report last year
1.0M
History used
2,877 days
the 14 Nov 2025 report24 earlier reportsnormal: 1.5M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
saw 60 13F filers open a new position in the quarter ended 31 Mar 2025, 3.2% below the same quarter last year.
Same quarter last year: 62; its normal quarter is 38.5.
See the evidence
This period
60 (the quarter ended 31 Mar 2025)
Normal quarter (median of 8 earlier)
38.5
Typical spread (median absolute deviation)
2.5
How far from its usual level
+5.6
Same quarter last year
62
History used
4,200 days
the quarter ended 31 Mar 20258 earlier quartersnormal: 38.5
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
saw 62 13F filers open a new position in the quarter ended 31 Mar 2024, 2.6× the same quarter last year.
Same quarter last year: 24; its normal quarter is 36.
See the evidence
This period
62 (the quarter ended 31 Mar 2024)
Normal quarter (median of 8 earlier)
36
Typical spread (median absolute deviation)
4.5
How far from its usual level
+3.9
Same quarter last year
24
History used
3,835 days
the quarter ended 31 Mar 20248 earlier quartersnormal: 36
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Showing the newest 40 of 102 entries; narrow the window or the kind of data to see older ones.
Not listed: 210 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it
Cik
0001674862
Ticker
ASH
Domain
ashland.com
Employer name
Ashland LLC (1 unverified)
Hq location
DE|WILMINGTON|19808 (1 unverified)
Lobbying client
ashland, ashland inc previously known as ashland
Name
565 Corporation, Ash GH One Inc, Ash GH Switzerland GmbH, ASH GP INC and 104 more
Wikidata
Q725634
Wikipedia
Ashland Global
DOL H-1B labor condition applications and PERM certifications20 data points6 Jul 2020 to 9 Dec 2024
Federal lobbying disclosures (LDA)12 records, 258 data points30 Jun 1999 to 30 Sep 2026
SEC Form 13F institutional holdings481 data points30 Jun 2013 to 30 Sep 2026
SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)205 records20 Sep 2016 to 20 Nov 2026
SEC XBRL company facts (revenue, capex, R&D, backlog...)726 data points30 Sep 2013 to 31 Oct 2026
SEC Form 4 insider transactions53 records, 172 data points16 Nov 2016 to 3 Feb 2025
FINRA short interest (twice monthly)636 data points29 Dec 2017 to 30 Oct 2026
FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
WARN layoff notices (state labor agencies)4 records, 12 data points28 Jul 2008 to 1 Jul 2025
Wikipedia pageviews2454 data points4 Mar 2020 to 21 Nov 2026